All Insights

Competition, antitrust and trade

CMA trains crosshairs on pricing algorithms and AI agents in the UK

The regulator is ramping up scrutiny of algorithmic pricing, third-party data tools and consumer-facing AI agents
Competition, antitrust and trade

UK government sets out plans to update investment screening rules

Revised definitions across eight sectors, a water schedule and fresh carve-outs for AI end-users take shape
GDPR for HR

GDPR for HR | March 2026

Data protection in internal investigations, use of AI in DSARs and recruitment, and deleted data DSAR obligations
Regulatory Outlook

Artificial intelligence | UK Regulatory Outlook March 2026

UK government position on copyright and AI | Lords Communications and Digital Committee calls on government to reject opt-out model
Regulatory Outlook

Consumer law | UK Regulatory Outlook March 2026

CMA sets out consumer law expectations for businesses deploying AI agents | Commencement of DMCCA alternative dispute resolution regime |
Intellectual property

Opted out: UK government moves away from preferred position on AI and copyright following report

No concrete policy decisions made; wide text and data mining copyright exception with opt-out no longer preferred approach; more information
Dispute resolution

AI tools and privilege in the UK – what are the risks?

Upper Tribunal gives strict warning on the privilege risks when using AI, distinguishing between 'open source' and closed tools
Regulatory and compliance

The regulation of consumer robotics

What are the implications for manufacturers?
Intellectual property

Supreme Court opens the door in the UK to patentability of AI inventions

UK brought into alignment with EPO as domestic approach to patentability of computer-implemented inventions overturned
Regulatory Outlook

Artificial intelligence | UK Regulatory Outlook February 2026

UK: AI Opportunities Action Plan: one year on | AI and copyright: recent comments from the government | New criminal
Life Sciences and Healthcare

Data-driven digital health businesses challenged with balancing AI advances and tighter regulation in 2026

Hyper-personalisation, data interoperability and AI are among 2025's fast-evolving areas to continue to watch this year
Life Sciences and Healthcare

EU MDR and IVDR poised to remain main framework for medical AI in draft AI interface reforms

Lex specialis treatment, integrated notified body reviews and clarified duties are designed to limit overlapping regulation of medical AI